Spinal Cord Injury Research Laboratory, Crawford Research Institute, Shepherd Center.
Division of Physical Therapy, School of Medicine, Emory University.
Curr Opin Neurol. 2021 Dec 1;34(6):812-818. doi: 10.1097/WCO.0000000000000997.
This review will focus on the use of clinically accessible neuromodulatory approaches for functional restoration in persons with spinal cord injury (SCI).
Functional restoration is a primary rehabilitation priority for individuals with SCI. High-tech neuromodulatory modalities have been used in laboratory settings to improve hand and walking function as well as to reduce spasticity and pain in persons with SCI. However, the cost, limited accessibility, and required expertise are prohibitive for clinical applicability of these high-tech modalities. Recent literature indicates that noninvasive and clinically accessible approaches targeting supraspinal, spinal, and peripheral neural structures can modulate neural excitability. Although a limited number of studies have examined the use of these approaches for functional restoration and amelioration of secondary complications in SCI, early evidence investigating their efficacy when combined with training is encouraging.
Larger sample studies addressing both biomarker identification and dosing are crucial next steps in the field of neurorehabilitation research before novel noninvasive stimulation approaches can be incorporated into standard clinical practice.
本文将重点介绍临床可用的神经调节方法在脊髓损伤(SCI)患者功能恢复中的应用。
功能恢复是 SCI 患者康复的首要重点。在实验室环境中,已使用高科技神经调节模式来改善手和行走功能,并减轻 SCI 患者的痉挛和疼痛。但是,这些高科技模式的成本高、可及性有限且需要专业知识,限制了其在临床中的应用。最近的文献表明,针对皮质上、脊髓和周围神经结构的非侵入性和临床可及的方法可以调节神经兴奋性。尽管少数研究探讨了这些方法在 SCI 功能恢复和改善继发性并发症中的应用,但当将这些方法与训练结合使用时,早期研究结果令人鼓舞。
在将新型非侵入性刺激方法纳入标准临床实践之前,神经康复研究领域需要进行更大规模的样本研究,以确定生物标志物并确定剂量,这是该领域的关键下一步。